Eagle Health Investments LP - Q2 2023 holdings

$535 Million is the total value of Eagle Health Investments LP's 27 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

 Value Shares↓ Weighting
OM  OUTSET MED INC$26,252,420
+18.9%
1,200,3850.0%4.91%
+14.1%
ALNY  ALNYLAM PHARMACEUTICALS INC$25,975,435
-5.2%
136,7560.0%4.86%
-8.9%
ARGX  ARGENX SEsponsored adr$25,098,612
+4.6%
64,4000.0%4.69%
+0.5%
ADPT  ADAPTIVE BIOTECHNOLOGIES COR$8,151,711
-24.0%
1,214,8600.0%1.52%
-27.0%
FDMT  4D MOLECULAR THERAPEUTICS IN$7,913,052
+5.1%
437,9110.0%1.48%
+1.0%
AGIO  AGIOS PHARMACEUTICALS INC$7,579,282
+23.3%
267,6300.0%1.42%
+18.4%
CANO  CANO HEALTH INC$5,964,352
+52.7%
4,290,9010.0%1.12%
+46.7%
AMWL  AMERICAN WELL CORPcl a$2,929,582
-11.0%
1,395,0390.0%0.55%
-14.5%
CMAX  CAREMAX INC$2,222,888
+16.5%
714,7550.0%0.42%
+11.8%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IQVIA HLDGS INC12Q3 20239.6%
UNITED THERAPEUTICS CORP DEL12Q3 20238.7%
ALNYLAM PHARMACEUTICALS INC12Q3 20238.5%
NATERA INC12Q3 20238.5%
ARGENX SE12Q3 20237.0%
DEXCOM INC12Q3 20235.7%
OUTSET MED INC12Q3 20237.3%
AGIOS PHARMACEUTICALS INC12Q3 20237.2%
ADAPTIVE BIOTECHNOLOGIES COR12Q3 20235.1%
GUARDANT HEALTH INC12Q3 20233.8%

View Eagle Health Investments LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-12
13F-HR2023-10-27
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-02-10

View Eagle Health Investments LP's complete filings history.

Compare quarters

Export Eagle Health Investments LP's holdings